Literature DB >> 22639193

The development of FtsZ inhibitors as potential antibacterial agents.

Siti Ma1, Shutao Ma.   

Abstract

The emergence and prevalence of bacterial resistance has resulted in a clear demand for novel antibacterial drugs. As a tubulin homologue, FtsZ is an essential cell-division protein in prokaryotic organisms and is showing increasing promise as a target for antibacterial drug discovery. This review describes the role of FtsZ in bacterial cytokinesis and various FtsZ inhibitors, with particular focus on their discovery, antibacterial activities, mechanisms of action, synthetic methods, and representative analogues.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Substances:

Year:  2012        PMID: 22639193     DOI: 10.1002/cmdc.201200156

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  18 in total

1.  Synthesis of the diaryl ether cores common to chrysophaentins A, E and F.

Authors:  Anthony J Brockway; Charles I Grove; Maximillian E Mahoney; Jared T Shaw
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

2.  Enterococcal and streptococcal resistance to PC190723 and related compounds: molecular insights from a FtsZ mutational analysis.

Authors:  Malvika Kaul; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Steve Tuske; Eddy Arnold; John E Kerrigan; Daniel S Pilch
Journal:  Biochimie       Date:  2013-06-25       Impact factor: 4.079

3.  Functional chromatographic technique for natural product isolation.

Authors:  Eric C Lau; Damian J Mason; Nicole Eichhorst; Pearce Engelder; Celestina Mesa; E M Kithsiri Wijeratne; G M Kamal B Gunaherath; A A Leslie Gunatilaka; James J La Clair; Eli Chapman
Journal:  Org Biomol Chem       Date:  2015-02-28       Impact factor: 3.876

4.  A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.

Authors:  Malvika Kaul; Ajit K Parhi; Yongzheng Zhang; Edmond J LaVoie; Steve Tuske; Eddy Arnold; John E Kerrigan; Daniel S Pilch
Journal:  J Med Chem       Date:  2012-10-26       Impact factor: 7.446

5.  An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivo.

Authors:  Malvika Kaul; Lilly Mark; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Daniel S Pilch
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.

Authors:  Alexander J Lepak; Ajit Parhi; Michaela Madison; Karen Marchillo; Jamie VanHecker; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

7.  Chrysophaentins are competitive inhibitors of FtsZ and inhibit Z-ring formation in live bacteria.

Authors:  Jessica L Keffer; Sonia Huecas; Jared T Hammill; Peter Wipf; Jose M Andreu; Carole A Bewley
Journal:  Bioorg Med Chem       Date:  2013-07-25       Impact factor: 3.641

8.  An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy.

Authors:  Neil R Stokes; Nicola Baker; James M Bennett; Joanne Berry; Ian Collins; Lloyd G Czaplewski; Alastair Logan; Rebecca Macdonald; Leanne Macleod; Hilary Peasley; Jeffrey P Mitchell; Narendra Nayal; Anju Yadav; Anil Srivastava; David J Haydon
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

9.  A novel quinoline derivative that inhibits mycobacterial FtsZ.

Authors:  Bini Mathew; Larry Ross; Robert C Reynolds
Journal:  Tuberculosis (Edinb)       Date:  2013-05-04       Impact factor: 3.131

10.  Comparison of small molecule inhibitors of the bacterial cell division protein FtsZ and identification of a reliable cross-species inhibitor.

Authors:  David E Anderson; Michelle B Kim; Jared T Moore; Terrence E O'Brien; Nohemy A Sorto; Charles I Grove; Laura L Lackner; James B Ames; Jared T Shaw
Journal:  ACS Chem Biol       Date:  2012-10-05       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.